| scholarly article | Q13442814 |
| P2093 | author name string | Costantino Iadecola | |
| Alexander E Merkler | |||
| Neal S Parikh | |||
| P2860 | cites work | Psoriasis and risk of atrial fibrillation and ischaemic stroke: a Danish Nationwide Cohort Study. | Q50554433 |
| Disease duration and severity impacts on long-term cardiovascular events in Japanese patients with rheumatoid arthritis. | Q50703759 | ||
| The risk of cardiovascular events in psoriasis patients treated with tumor necrosis factor-α inhibitors versus phototherapy: An observational cohort study. | Q51745198 | ||
| Influenza-like illness as a trigger for ischemic stroke. | Q55264807 | ||
| Periodontal diseases | Q56115988 | ||
| Clinical activity is an independent risk factor of ischemic heart and cerebrovascular arterial disease in patients with inflammatory bowel disease | Q58782501 | ||
| Association of herpesviruses and stroke: Systematic review and meta-analysis | Q59350410 | ||
| High Levels of Soluble Lectinlike Oxidized Low-Density Lipoprotein Receptor-1 Are Associated With Carotid Plaque Inflammation and Increased Risk of Ischemic Stroke | Q64241987 | ||
| Neurosyphilis. A study of 241 patients | Q70465397 | ||
| C-reactive protein predicts further ischemic events in first-ever transient ischemic attack or stroke patients with intracranial large-artery occlusive disease | Q79074576 | ||
| Stroke and syphilis: A retrospective study of 53 patients | Q88310210 | ||
| CNS Vasculitis: an Approach to Differential Diagnosis and Management | Q88917571 | ||
| Rheumatoid arthritis significantly increased recurrence risk after ischemic stroke/transient ischemic attack | Q88962201 | ||
| The elevated lipoprotein-associated phospholipase A2 activity is associated with the occurrence and recurrence of acute cerebral infarction | Q89437938 | ||
| Poststroke Depression Biomarkers: A Narrative Review | Q90650069 | ||
| Risk of adverse outcomes in patients with rheumatoid arthritis hospitalized for stroke-a cross-sectional study | Q91413099 | ||
| Low-Dose Methotrexate for the Prevention of Atherosclerotic Events | Q92980641 | ||
| Syphilis: review with emphasis on clinical, epidemiologic, and some biologic features | Q24550725 | ||
| Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein | Q29547752 | ||
| Cerebrovascular Disease in Rheumatic Diseases: A Systematic Review and Meta-Analysis | Q31049345 | ||
| Nephritis and the risk of acute myocardial infarction in patients with systemic lupus erythematosus | Q33389669 | ||
| Tuberculous cerebrovascular disease: a review | Q33487535 | ||
| Excess atherosclerosis in systemic lupus erythematosus,-A matter of renal involvement: Case control study of 281 SLE patients and 281 individually matched population controls | Q33570432 | ||
| Cerebral angiopathy and recurrent strokes following Borrelia burgdorferi infection | Q33630048 | ||
| Infection and atherosclerosis: emerging mechanistic paradigms | Q33696699 | ||
| Infectious burden and risk of stroke: the northern Manhattan study | Q33697873 | ||
| Risk of stroke in patients with rheumatism: a nationwide longitudinal population-based study. | Q33714074 | ||
| The relationship between herpes zoster and stroke | Q33848018 | ||
| Infectious burden: a new risk factor and treatment target for atherosclerosis | Q33936406 | ||
| Post-stroke infection: a systematic review and meta-analysis | Q34024634 | ||
| Rosuvastatin in the prevention of stroke among men and women with elevated levels of C-reactive protein: justification for the Use of Statins in Prevention: an Intervention Trial Evaluating Rosuvastatin (JUPITER). | Q34089358 | ||
| Tuberculosis and the risk of ischemic stroke: a 3-year follow-up study. | Q34089964 | ||
| The varicella zoster virus vasculopathies: clinical, CSF, imaging, and virologic features. | Q34124520 | ||
| Explaining the cardiovascular risk associated with rheumatoid arthritis: traditional risk factors versus markers of rheumatoid arthritis severity | Q34238357 | ||
| Association of circulating inflammatory markers with recurrent vascular events after stroke: a prospective cohort study | Q34469067 | ||
| Hospitalization for infection and risk of acute ischemic stroke: the Cardiovascular Health Study | Q35074776 | ||
| The effects of tumour necrosis factor inhibitors, methotrexate, non-steroidal anti-inflammatory drugs and corticosteroids on cardiovascular events in rheumatoid arthritis, psoriasis and psoriatic arthritis: a systematic review and meta-analysis. | Q35135831 | ||
| Association between Helicobacter pylori infection and stroke: a meta-analysis of prospective observational studies | Q35282900 | ||
| Inflammation and infections as risk factors for ischemic stroke | Q35538798 | ||
| Disease activity in rheumatoid arthritis and the risk of cardiovascular events | Q35655764 | ||
| Risk of atrial fibrillation and stroke in rheumatoid arthritis: Danish nationwide cohort study | Q35815364 | ||
| Exploratory Cohort Study of Associations between Serum C - Reactive Protein and Fatigue after Stroke | Q35849721 | ||
| Combination of the Immune Modulator Fingolimod With Alteplase in Acute Ischemic Stroke: A Pilot Trial | Q36087056 | ||
| Brain arterial remodeling contribution to nonembolic brain infarcts in patients with HIV. | Q36156701 | ||
| Cardiovascular risk in rheumatoid arthritis: comparing TNF-α blockade with nonbiologic DMARDs | Q36361147 | ||
| HIV infection as vascular risk: A systematic review of the literature and meta-analysis | Q36368959 | ||
| Neurological complications after tuberculous meningitis in a multi-state cohort in the United States. | Q40284504 | ||
| Cardiovascular event risk assessment in psoriasis patients treated with tumor necrosis factor-α inhibitors versus methotrexate. | Q40452981 | ||
| Is ankylosing spondylitis a risk factor for cardiovascular disease, and how do these risks compare with those in rheumatoid arthritis? | Q40709084 | ||
| Anti-inflammatory treatment and risk for depression after first-time stroke in a cohort of 147 487 Danish patients | Q41535865 | ||
| Association between antiviral treatment and extrahepatic outcomes in patients with hepatitis C virus infection | Q41660591 | ||
| Increased risk of ischaemic stroke amongst patients with chronic osteomyelitis: a population-based cohort study in Taiwan. | Q42225383 | ||
| Reduction in High-Sensitivity C-Reactive Protein Levels in Patients with Ischemic Stroke by Statin Treatment: Hs-CRP Sub-Study in J-STARS | Q42629551 | ||
| Statin treatment and stroke outcome in the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial. | Q43278301 | ||
| Associations of proinflammatory cytokines with the risk of recurrent stroke | Q43546564 | ||
| Polymyalgia rheumatica and the risk of stroke: a three-year follow-up study | Q43722950 | ||
| Inflammation, hemostatic markers, and antithrombotic agents in relation to long-term risk of new cardiovascular events in first-ever ischemic stroke patients | Q44053916 | ||
| Interleukin-6 as an early predictor for one-year survival following an ischaemic stroke/transient ischaemic attack. | Q44057536 | ||
| The association between inflammatory markers, serum lipids and the risk of cardiovascular events in patients with rheumatoid arthritis | Q44558171 | ||
| Progression of atherosclerosis as assessed by carotid intima-media thickness in patients with HIV infection | Q44801351 | ||
| Tuberculous meningitis in patients infected with the human immunodeficiency virus | Q45008897 | ||
| Cytomegalovirus antigen within human arterial smooth muscle cells | Q45224814 | ||
| Hepatitis C virus infection and increased risk of cerebrovascular disease. | Q45372162 | ||
| Risk factors, inpatient care, and outcomes of pneumonia after ischemic stroke | Q45717807 | ||
| Herpes zoster ophthalmicus and the risk of stroke: a population-based follow-up study | Q45758822 | ||
| Cognitive decline after stroke: relation to inflammatory biomarkers and hippocampal volume | Q45882428 | ||
| Impact of risk factors associated with cardiovascular outcomes in patients with rheumatoid arthritis. | Q46027578 | ||
| Should preventive antibiotics be used in patients with acute stroke? A systematic review and meta-analysis of randomized controlled trials | Q47099868 | ||
| Safety and efficacy of natalizumab in patients with acute ischaemic stroke (ACTION): a randomised, placebo-controlled, double-blind phase 2 trial. | Q47432077 | ||
| Elevated circulating homocysteine and high-sensitivity C-reactive protein jointly predicts post-stroke depression among Chinese patients with acute ischemic stroke | Q47657922 | ||
| Effects of interleukin-6, interleukin-18, and statin use, evaluated at acute stroke, on post-stroke depression during 1-year follow-up | Q47980462 | ||
| Statin use increases the risk of depressive disorder in stroke patients: a population-based study | Q48009651 | ||
| Inflammatory markers and their association with post stroke cognitive decline | Q48126895 | ||
| High-sensitivity C-reactive protein, lipoprotein-associated phospholipase A2, and outcome after ischemic stroke | Q48389128 | ||
| A prospective study of statin use and poststroke depression | Q48391167 | ||
| Inflammation markers and prediction of post-stroke vascular disease recurrence: the MITICO study. | Q48720131 | ||
| Prognostic influence of increased C-reactive protein and fibrinogen levels in ischemic stroke | Q49119777 | ||
| The relationship between inflammatory markers and post stroke cognitive impairment | Q49142541 | ||
| Periodontal Disease, Regular Dental Care Use, and Incident Ischemic Stroke | Q50043250 | ||
| Increased Levels of Lectin-Like Oxidized Low-Density Lipoprotein Receptor-1 in Ischemic Stroke and Transient Ischemic Attack | Q50059271 | ||
| Central nervous system viral invasion and inflammation during acute HIV infection | Q36376213 | ||
| Incidence of and risk factors for adverse cardiovascular events among patients with systemic lupus erythematosus | Q36606667 | ||
| Herpesvirus Infections and Childhood Arterial Ischemic Stroke: Results of the VIPS Study | Q36614560 | ||
| Inflammatory Markers and Outcomes After Lacunar Stroke: Levels of Inflammatory Markers in Treatment of Stroke Study | Q36614676 | ||
| Predicting cardiovascular risk in England and Wales: prospective derivation and validation of QRISK2. | Q36738148 | ||
| Psoriasis and major adverse cardiovascular events: a systematic review and meta-analysis of observational studies | Q36824796 | ||
| Hydroxychloroquine Use Is Associated With Decreased Incident Cardiovascular Events in Rheumatoid Arthritis Patients | Q36877859 | ||
| Brain large artery inflammation associated with HIV and large artery remodeling. | Q37547729 | ||
| Population-based study of blood biomarkers in prediction of subacute recurrent stroke | Q37737232 | ||
| Association between infectious burden, socioeconomic status, and ischemic stroke | Q37835594 | ||
| The association of seropositivity to Helicobacter pylori, Chlamydia pneumoniae, and cytomegalovirus with risk of cardiovascular disease: a prospective study | Q37870997 | ||
| Increased circulating immune complexes in acute stroke: the triggering role of Chlamydia pneumoniae and cytomegalovirus | Q37872208 | ||
| Statin therapy and outcome after ischemic stroke: systematic review and meta-analysis of observational studies and randomized trials. | Q38071519 | ||
| Infectious causes of stroke | Q38216450 | ||
| Prognostic value of blood interleukin-6 in the prediction of functional outcome after stroke: a systematic review and meta-analysis. | Q38236852 | ||
| Risk of ischemic stroke in patients with polymyositis and dermatomyositis: a systematic review and meta-analysis | Q38263671 | ||
| High-Sensitive C-Reactive Protein Predicts Recurrent Stroke and Poor Functional Outcome: Subanalysis of the Clopidogrel in High-Risk Patients With Acute Nondisabling Cerebrovascular Events Trial | Q38391056 | ||
| Glucocorticoids and cardiovascular and cerebrovascular events in polymyalgia rheumatica. | Q38463783 | ||
| Risk of Stroke in Patients with Inflammatory Bowel Disease: A Systematic Review and Meta-analysis | Q38584951 | ||
| Association between chronic immune-mediated inflammatory diseases and cardiovascular risk. | Q38605189 | ||
| Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease | Q38606033 | ||
| The relationship between duration of psoriasis, vascular inflammation, and cardiovascular events | Q38615718 | ||
| Cytomegalovirus Infection and Relative Risk of Cardiovascular Disease (Ischemic Heart Disease, Stroke, and Cardiovascular Death): A Meta-Analysis of Prospective Studies Up to 2016. | Q38661693 | ||
| Cardiovascular and type 2 diabetes morbidity and all-cause mortality among diverse chronic inflammatory disorders | Q38732135 | ||
| Association between periodontitis and ischemic stroke: a systematic review and meta-analysis | Q38864934 | ||
| Blood/Brain Biomarkers of Inflammation After Stroke and Their Association With Outcome: From C-Reactive Protein to Damage-Associated Molecular Patterns. | Q38931129 | ||
| Inflammatory risk factors, biomarkers and associated therapy in ischaemic stroke | Q38951255 | ||
| Risk of Acute Stroke After Hospitalization for Sepsis: A Case-Crossover Study | Q38961607 | ||
| Inflammation and Stroke: An Overview | Q38978527 | ||
| Inflammatory bowel diseases increase future ischemic stroke risk: a Taiwanese population-based retrospective cohort study | Q39179288 | ||
| Cerebrovascular Manifestations of Lyme Neuroborreliosis-A Systematic Review of Published Cases | Q39284826 | ||
| Poststroke Fatigue: Emerging Evidence and Approaches to Management: A Scientific Statement for Healthcare Professionals From the American Heart Association. | Q39331271 | ||
| The frequency of poststroke infections and their impact on early stroke outcome | Q39364159 | ||
| Risk of myocardial infarction and stroke after acute infection or vaccination | Q39471364 | ||
| A guiding map for inflammation | Q40128384 | ||
| P433 | issue | 3 | |
| P304 | page(s) | 711-718 | |
| P577 | publication date | 2020-02-12 | |
| P1433 | published in | Stroke Journal | Q7624282 |
| P1476 | title | Inflammation, Autoimmunity, Infection, and Stroke: Epidemiology and Lessons From Therapeutic Intervention | |
| P478 | volume | 51 |
| Q95840629 | Editorial: The Anatomical Basis of the Cross Talk Between Immune System and Brain | cites work | P2860 |
Search more.